5-Fluorouracil, Doxorubicin, Cyclophosphamide (5FAC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 5-Fluorouracil, Doxorubicin, Cyclophosphamide (5FAC), covering 2020-12-04 to 2020-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment [Phase 3]